Update shared on 12 Nov 2025
Fair value Increased 3.86%Analysts have raised their price target for American Healthcare REIT from $46.92 to $48.73. They cite improved profit margins and a lower discount rate as key factors behind the positive revision.
What's in the News
- Raised financial guidance for the full year ending December 31, 2025, with net income per diluted share now projected between $0.47 and $0.50, compared to previous guidance of $0.33 to $0.37 (Key Developments)
- Expected same-store net operating income growth increased to 13.0% to 15.0%, up from 11.0% to 14.0% (Key Developments)
- Net income attributable to common stockholders is now forecasted at $78.00 million to $83.00 million, higher than prior guidance of $53.70 million to $60.50 million (Key Developments)
- Reported impairment charges of $3,768,000 on real estate investments for the three months ended September 30, 2025 (Key Developments)
Valuation Changes
- Fair Value Estimate has risen slightly, from $46.92 to $48.73 per share.
- Discount Rate has fallen modestly, from 7.30% to 7.24%.
- Revenue Growth Expectation has decreased noticeably, from 7.78% to 5.46%.
- Net Profit Margin has improved significantly, moving from 7.65% to 12.57%.
- Future Price-to-Earnings (P/E) Ratio is projected to decline from 58.2x to 40.1x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.